- Article
Identification of Novel HPK1 Hit Inhibitors: From In Silico Design to In Vitro Validation
- Israa H. Isawi,
- Rayan M. Obeidat,
- Soraya Alnabulsi and
- Rufaida Al Zoubi
Hematopoietic progenitor kinase 1 (HPK1), a negative regulator of T-cells, B-cells, and dendritic cells, has gained attention in antitumor immunotherapy research over the past decade. No HPK1 inhibitor has yet reached clinical approval, largely due t...